Le Lézard
Classified in: Health, Science and technology
Subject: TDS

Thryv Therapeutics to Participate in the 2025 Piper Sandler Virtual Cardio Day


MONTREAL, March 27, 2025 /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is pleased to announce its participation in the 2025 Piper Sandler Virtual Cardio Day on April 1, 2025.

Thryv's leadership team will take part in a fireside chat from 11:30?11:55 a.m. ET to discuss the company's latest advancements in cardiovascular research. The discussion will focus on Thryv's progress in developing novel SGK1 inhibitors for the treatment of Long QT Syndrome, heart failure, and atrial fibrillation.

Thryv Therapeutics Fireside Chat
Date: April 1, 2025
Time: 11:30?11:55 a.m. ET
Participants:

The Piper Sandler Virtual Cardio Day is an invitation-only event for Piper Sandler clients. For additional details or to request access to the webcast, please contact your Piper Sandler representative.

About Thryv Therapeutics

Thryv Therapeutics Inc. is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to develop potent and highly selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) to treat Long QT Syndrome, heart failure and atrial fibrillation.  For more information, please visit www.thryvtrx.com.  

SOURCE Thryv Therapeutics Inc.


These press releases may also interest you

at 20:00
VeriSilicon Introduces AcuityPercept: an AI-Powered Automatic ISP Tuning System
VeriSilicon (688521.SH) today announced AcuityPercept, its AI-based automatic Image Signal Processing (ISP) tuning system, designed to intelligently optimize image processing parameters for enhanced object recognition. AcuityPercept improves the...

at 19:00
ISG Announces 2025 ISG Paragon Awardstm ANZ Finalists
Information Services Group (ISG) , a global AI-centered technology research and advisory firm, today announced the finalists for the 2025 ISG Paragon Awardstm ANZ, which recognize innovative sourcing partnerships that help enterprises leverage...

at 18:13
Li-S Energy collaborates with Kea Aerospace to power high altitude UAV flights
Li-S Energy ('Li-S' or 'the Company') has signed a collaboration agreement with Kea Aerospace (Kea) to integrate Li-S' advanced lithium sulfur battery technology into Kea's high altitude UAVs targeting multi-month flight times....

at 17:06
Patent Index 2024: Japan ranks 3rd in European patent applications
According to the latest Patent Index 2024, published today by the European Patent Office (EPO), Japan ranked third worldwide, following the United States and Germany. In 2024, Japanese companies and inventors filed a total of 21,062 patent...

at 17:06
Patent Index 2024: R. Korea Secures Top 5 Spot for Second Consecutive Year, Proving Its Strength in Innovation
The European Patent Office (EPO) published its annual Patent Index 2024 today, revealing that a total of 199,264 European patent applications were filed last year. This figure is nearly identical to that of 2023 (199,452), indicating that after three...

at 15:15
Clinical Data Presented at ACC 2025 Shows Sensydia CPStm Provides Accurate Assessment of Mean Pulmonary Artery Pressure Non-Invasively
Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the company's AI-powered, non-invasive Cardiac...

More news about Science and technology...


News published on and distributed by: